Science 37 was founded more than a decade ago by investigators with the vision to make clinical research accessible to anyone, anywhere, anytime, regardless of their proximity to research sites.

Science 37 provides mobile research nursing solutions designed to help clinical trial sponsors boost study enrollment by offering participants the convenience of in-home visits.

Science 37 is the first FDA-inspected direct-to-patient clinical trial site, making research more accessible and accelerating breakthroughs through innovative, patient-focused solutions.

The Site That Visits The Patient Science 37’s Direct-to-Patient Site enables sponsors to reach 100% of their target patient population by conducting study visits in patients’ homes.

With most studies likely including a combination of traditional and virtual sites, Science 37 has examined the cost and value impact of differing numbers of brick-and-mortar sites deployed in combination with …

Science 37 makes it easier to participate in clinical research from the comfort of your home while improving your experience as a participant. See below for the list of active and enrolling clinical trials. …

Science 37 enables both patients and providers to participate in clinical trials. To learn more, choose the option below that is relevant to you.

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial Science 37, a leader in enhancing patient access to clinical trials, today …

Log in to your account Email

MORRISVILLE, NC — January 7, 2026 — Science 37, the leader in expanding patient access to clinical trials, today announced it has been named a finalist for two prestigious SCOPE Awards: the …